BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 34575784)

  • 1. Virulence Factors and in-Host Selection on Phenotypes in Infectious Probiotic Yeast Isolates (
    Imre A; Kovács R; Pázmándi K; Nemes D; Jakab Á; Fekete T; Rácz HV; Dóczi I; Bácskay I; Gácser A; Kovács K; Majoros L; Farkas Z; Pócsi I; Pfliegler WP
    J Fungi (Basel); 2021 Sep; 7(9):. PubMed ID: 34575784
    [No Abstract]   [Full Text] [Related]  

  • 2. Heme Oxygenase-1 (
    Imre A; Kovács R; Tóth Z; Majoros L; Benkő Z; Pfliegler WP; Pócsi I
    J Fungi (Basel); 2022 May; 8(5):. PubMed ID: 35628777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review article: yeast as probiotics -- Saccharomyces boulardii.
    Czerucka D; Piche T; Rampal P
    Aliment Pharmacol Ther; 2007 Sep; 26(6):767-78. PubMed ID: 17767461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new, rapid multiplex PCR method identifies frequent probiotic origin among clinical Saccharomyces isolates.
    Imre A; Rácz HV; Antunovics Z; Rádai Z; Kovács R; Lopandic K; Pócsi I; Pfliegler WP
    Microbiol Res; 2019 Oct; 227():126298. PubMed ID: 31421716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular tools for differentiating probiotic and clinical strains of Saccharomyces cerevisiae.
    Posteraro B; Sanguinetti M; Romano L; Torelli R; Novarese L; Fadda G
    Int J Food Microbiol; 2005 Sep; 103(3):295-304. PubMed ID: 16099314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Yeasts as probiotics: Mechanisms, outcomes, and future potential.
    Sen S; Mansell TJ
    Fungal Genet Biol; 2020 Apr; 137():103333. PubMed ID: 31923554
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Pais P; Almeida V; Yılmaz M; Teixeira MC
    J Fungi (Basel); 2020 Jun; 6(2):. PubMed ID: 32512834
    [No Abstract]   [Full Text] [Related]  

  • 8. A Mutation in
    Liu JJ; Zhang GC; Kong II; Yun EJ; Zheng JQ; Kweon DH; Jin YS
    Appl Environ Microbiol; 2018 May; 84(10):. PubMed ID: 29523547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health-promoting properties of
    Ansari F; Alian Samakkhah S; Bahadori A; Jafari SM; Ziaee M; Khodayari MT; Pourjafar H
    Crit Rev Food Sci Nutr; 2023; 63(4):457-485. PubMed ID: 34254862
    [No Abstract]   [Full Text] [Related]  

  • 10. Characterization of the Probiotic Yeast Saccharomyces boulardii in the Healthy Mucosal Immune System.
    Hudson LE; McDermott CD; Stewart TP; Hudson WH; Rios D; Fasken MB; Corbett AH; Lamb TJ
    PLoS One; 2016; 11(4):e0153351. PubMed ID: 27064405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Species identification and virulence attributes of Saccharomyces boulardii (nom. inval.).
    McCullough MJ; Clemons KV; McCusker JH; Stevens DA
    J Clin Microbiol; 1998 Sep; 36(9):2613-7. PubMed ID: 9705402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unique genetic basis of the distinct antibiotic potency of high acetic acid production in the probiotic yeast
    Offei B; Vandecruys P; De Graeve S; Foulquié-Moreno MR; Thevelein JM
    Genome Res; 2019 Sep; 29(9):1478-1494. PubMed ID: 31467028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional heterologous protein expression by genetically engineered probiotic yeast Saccharomyces boulardii.
    Hudson LE; Fasken MB; McDermott CD; McBride SM; Kuiper EG; Guiliano DB; Corbett AH; Lamb TJ
    PLoS One; 2014; 9(11):e112660. PubMed ID: 25391025
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Lenka S; Singh D; Paul S; Gayen A; Chandra M
    ACS Infect Dis; 2021 Apr; 7(4):733-745. PubMed ID: 33703881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-Saccharomyces yeasts protect against epithelial cell barrier disruption induced by Salmonella enterica subsp. enterica serovar Typhimurium.
    Smith IM; Baker A; Arneborg N; Jespersen L
    Lett Appl Microbiol; 2015 Nov; 61(5):491-7. PubMed ID: 26280244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Commercial strain-derived clinical Saccharomyces cerevisiae can evolve new phenotypes without higher pathogenicity.
    Pfliegler WP; Boros E; Pázmándi K; Jakab Á; Zsuga I; Kovács R; Urbán E; Antunovics Z; Bácsi A; Sipiczki M; Majoros L; Pócsi I
    Mol Nutr Food Res; 2017 Nov; 61(11):. PubMed ID: 28731263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antioxidant properties and global metabolite screening of the probiotic yeast Saccharomyces cerevisiae var. boulardii.
    Datta S; Timson DJ; Annapure US
    J Sci Food Agric; 2017 Jul; 97(9):3039-3049. PubMed ID: 27868205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Saccharomyces boulardii CNCM I-745 influences the gut-associated immune system].
    Stier H; Bischoff SC
    MMW Fortschr Med; 2017 Jun; 159(Suppl 5):1-6. PubMed ID: 28643294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Saccharomyces boulardii ameliorates Citrobacter rodentium-induced colitis through actions on bacterial virulence factors.
    Wu X; Vallance BA; Boyer L; Bergstrom KS; Walker J; Madsen K; O'Kusky JR; Buchan AM; Jacobson K
    Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G295-306. PubMed ID: 18032474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probiotic and Potentially Probiotic Yeasts-Characteristics and Food Application.
    Staniszewski A; Kordowska-Wiater M
    Foods; 2021 Jun; 10(6):. PubMed ID: 34200217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.